Robert L. Stolfi

Improving the anti-tumor activity of 5-fluorouracil by increasing its incorporation into RNA via metabolic modulation.

S. Spiegelman, Robert C. Sawyer, R. Nayak et al. · Proceedings of the National Academy of Sciences · 1980 · 119 citations

Chemoprevention Strategy, Tumor Biology, Anti-cancer Agent +16

Immune Lytic Transformation: A State of Irreversible Damage Generated as a Result of the Reaction of the Eighth Component in the Guinea Pig Complement System

Robert L. Stolfi · The Journal of Immunology · 1968 · 112 citations

Low Osmotic Pressure, Humoral Response, Immunology +23

High-dose 5-fluorouracil with delayed uridine "rescue" in mice.

Daniel Martín, Robert L. Stolfi, Robert C. Sawyer et al. · PubMed · 1982 · 103 citations

Oncology, Health Sciences, Delayed Uridine +15

Potentiation of the anti-tumor activity of 5FU by thymidine and its correlation with the formation of (5FU) RNA

S. Spiegelman, R. Nayak, Robert C. Sawyer et al. · Cancer · 1980 · 79 citations · Full text

Antitumor Activity, Molecular Biology, Cancer Biology +21

Therapeutic utility of utilizing low doses of N-(phosphonacetyl)-L-aspartic acid in combination with 5-fluorouracil: a murine study with clinical relevance.

Daniel Martín, Robert L. Stolfi, Robert C. Sawyer et al. · PubMed · 1983 · 74 citations

Oncology, Chemoprevention Strategy, Therapeutic Utility +14